НовостиBenzingaCitigroup Maintains Buy on SpyGlass Pharma, Raises Price Target to $45 Citigroup Maintains Buy on SpyGlass Pharma, Raises Price Target to $45 Benzinga 2026.11.13 21:24 (GMT+0) Открыть на Benzinga Другие новости